We are live on
!
Find out more
CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
22 hedge funds and large institutions have $16.1M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding
Funds holding: 22 → 22 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
22
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.1M | |
| 2 | +$349K | |
| 3 | +$230K | |
| 4 |
LWPC
Legacy Wealth Partners (California)
Calabasas,
California
|
+$164K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$131K |
Top Sellers
| 1 | -$876K | |
| 2 | -$55K | |
| 3 | -$32K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$26K |
| 5 |
LPL Financial
San Diego,
California
|
-$25.5K |